CovidChloroV1, Main, Corpus, bibRecord, 000089

Experimental therapies under investigation for COVID-19.

Identifieur interne : 000089 ( Main/Corpus ); précédent : 000088; suivant : 000090

Experimental therapies under investigation for COVID-19.

Auteurs : Reshma Golamari ; Neeru Kapoor ; Tanuja Devaraj ; Nitasa Sahu ; Courtney Kramer ; Rohit Jain

Source :

Journal of community hospital internal medicine perspectives [ 2000-9666 ] ; 2021.

RBID : pubmed:33889318

Abstract

Coronavirus Disease 2019, caused by the virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has claimed over 1.7 million lives to date across the globe as of 24 December 2020. As the virus spreads across the world affecting millions of patients, there has been a massive movement to discover readily available and effective treatment options including vaccines. One of the limiting factors in treating the disease is its varied presentation and effect in patients, ranging from asymptomatic patients to those left in intensive care units, intubated and fighting for their lives. There are numerous clinical trials and small-scale studies underway to investigate potential treatment options. However, very few studies and drugs demonstrated efficacy while many more are under investigation, leaving care teams dependent on supportive care coupled with experimental treatment options. In this review, we summarize the various treatment options explored to treat COVID-19, discussing possible the mechanisms of fighting the virus.

DOI: 10.1080/20009666.2021.1874093
PubMed: 33889318
PubMed Central: PMC8043541

Links to Exploration step

pubmed:33889318

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Experimental therapies under investigation for COVID-19.</title>
<author><name sortKey="Golamari, Reshma" sort="Golamari, Reshma" uniqKey="Golamari R" first="Reshma" last="Golamari">Reshma Golamari</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kapoor, Neeru" sort="Kapoor, Neeru" uniqKey="Kapoor N" first="Neeru" last="Kapoor">Neeru Kapoor</name>
<affiliation><nlm:affiliation>Microbiologist, Maulana Azad Medical College, New Delhi, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Devaraj, Tanuja" sort="Devaraj, Tanuja" uniqKey="Devaraj T" first="Tanuja" last="Devaraj">Tanuja Devaraj</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sahu, Nitasa" sort="Sahu, Nitasa" uniqKey="Sahu N" first="Nitasa" last="Sahu">Nitasa Sahu</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kramer, Courtney" sort="Kramer, Courtney" uniqKey="Kramer C" first="Courtney" last="Kramer">Courtney Kramer</name>
<affiliation><nlm:affiliation>Penn State College of Medicine, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jain, Rohit" sort="Jain, Rohit" uniqKey="Jain R" first="Rohit" last="Jain">Rohit Jain</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33889318</idno>
<idno type="pmid">33889318</idno>
<idno type="doi">10.1080/20009666.2021.1874093</idno>
<idno type="pmc">PMC8043541</idno>
<idno type="wicri:Area/Main/Corpus">000089</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000089</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Experimental therapies under investigation for COVID-19.</title>
<author><name sortKey="Golamari, Reshma" sort="Golamari, Reshma" uniqKey="Golamari R" first="Reshma" last="Golamari">Reshma Golamari</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kapoor, Neeru" sort="Kapoor, Neeru" uniqKey="Kapoor N" first="Neeru" last="Kapoor">Neeru Kapoor</name>
<affiliation><nlm:affiliation>Microbiologist, Maulana Azad Medical College, New Delhi, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Devaraj, Tanuja" sort="Devaraj, Tanuja" uniqKey="Devaraj T" first="Tanuja" last="Devaraj">Tanuja Devaraj</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sahu, Nitasa" sort="Sahu, Nitasa" uniqKey="Sahu N" first="Nitasa" last="Sahu">Nitasa Sahu</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kramer, Courtney" sort="Kramer, Courtney" uniqKey="Kramer C" first="Courtney" last="Kramer">Courtney Kramer</name>
<affiliation><nlm:affiliation>Penn State College of Medicine, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jain, Rohit" sort="Jain, Rohit" uniqKey="Jain R" first="Rohit" last="Jain">Rohit Jain</name>
<affiliation><nlm:affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of community hospital internal medicine perspectives</title>
<idno type="ISSN">2000-9666</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Coronavirus Disease 2019, caused by the virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has claimed over 1.7 million lives to date across the globe as of 24 December 2020. As the virus spreads across the world affecting millions of patients, there has been a massive movement to discover readily available and effective treatment options including vaccines. One of the limiting factors in treating the disease is its varied presentation and effect in patients, ranging from asymptomatic patients to those left in intensive care units, intubated and fighting for their lives. There are numerous clinical trials and small-scale studies underway to investigate potential treatment options. However, very few studies and drugs demonstrated efficacy while many more are under investigation, leaving care teams dependent on supportive care coupled with experimental treatment options. In this review, we summarize the various treatment options explored to treat COVID-19, discussing possible the mechanisms of fighting the virus.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33889318</PMID>
<DateRevised><Year>2021</Year>
<Month>05</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2000-9666</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>2</Issue>
<PubDate><Year>2021</Year>
<Month>Mar</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Journal of community hospital internal medicine perspectives</Title>
<ISOAbbreviation>J Community Hosp Intern Med Perspect</ISOAbbreviation>
</Journal>
<ArticleTitle>Experimental therapies under investigation for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>187-193</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/20009666.2021.1874093</ELocationID>
<Abstract><AbstractText>Coronavirus Disease 2019, caused by the virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has claimed over 1.7 million lives to date across the globe as of 24 December 2020. As the virus spreads across the world affecting millions of patients, there has been a massive movement to discover readily available and effective treatment options including vaccines. One of the limiting factors in treating the disease is its varied presentation and effect in patients, ranging from asymptomatic patients to those left in intensive care units, intubated and fighting for their lives. There are numerous clinical trials and small-scale studies underway to investigate potential treatment options. However, very few studies and drugs demonstrated efficacy while many more are under investigation, leaving care teams dependent on supportive care coupled with experimental treatment options. In this review, we summarize the various treatment options explored to treat COVID-19, discussing possible the mechanisms of fighting the virus.</AbstractText>
<CopyrightInformation>© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Golamari</LastName>
<ForeName>Reshma</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-8842-9762</Identifier>
<AffiliationInfo><Affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kapoor</LastName>
<ForeName>Neeru</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Microbiologist, Maulana Azad Medical College, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Devaraj</LastName>
<ForeName>Tanuja</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sahu</LastName>
<ForeName>Nitasa</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-4767-9095</Identifier>
<AffiliationInfo><Affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kramer</LastName>
<ForeName>Courtney</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Penn State College of Medicine, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jain</LastName>
<ForeName>Rohit</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Assistant Professor of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>03</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Community Hosp Intern Med Perspect</MedlineTA>
<NlmUniqueID>101601396</NlmUniqueID>
<ISSNLinking>2000-9666</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 treatment</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">pandemic drugs</Keyword>
<Keyword MajorTopicYN="N">remdesivir</Keyword>
<Keyword MajorTopicYN="N">therapies for COVID-19</Keyword>
</KeywordList>
<CoiStatement>The authors do not have financial relationships with any commercial entity that has an interest in the subject of the presented manuscript or other conflicts of interest to disclose.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>4</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>26</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33889318</ArticleId>
<ArticleId IdType="doi">10.1080/20009666.2021.1874093</ArticleId>
<ArticleId IdType="pii">1874093</ArticleId>
<ArticleId IdType="pmc">PMC8043541</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2020 Sep;20(9):1013-1014</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32251639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32391667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2020 Apr;26(4):450-452</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32284615</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Apr 28;323(16):1582-1589</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32219428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32835257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 29;395(10225):689-697</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32014114</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2019 Jul;167:45-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30974127</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2021 Jan 21;384(3):238-251</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33332778</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Transl Med. 2020 May;8(10):627</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32566564</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Aug 4;324(5):460-470</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492084</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33264556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Immunol. 2021 Jan;42(1):3-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33214057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2021 Jan 21;384(3):229-237</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33113295</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2017 Jun 28;9(396):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28659436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26198719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Public Health. 2018 Jan - Feb;11(1):9-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28864360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2019 Sep;169:104541</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31233808</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Oct;2(10):e603-e612</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ecancermedicalscience. 2020 Mar 30;14:1023</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32256706</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Jun;86(12):6537-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22496216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):317-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 5;383(19):1827-1837</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32459919</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>mBio. 2018 Mar 6;9(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29511076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32054787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2021 Mar 4;384(9):795-807</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33306283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Dec 10;383(24):2333-2344</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33085857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ecancermedicalscience. 2020 Mar 27;14:1022</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32256705</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2013 Dec;67(6):606-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24096239</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2020 May 01;11:827</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32425950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2020 Mar 16;24(1):91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32178711</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1851-1852</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2020 May;20(5):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32213337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Crit Care. 2020 Jun;57:279-283</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32173110</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2002 Apr;46(4):977-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11897578</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stem Cell Res Ther. 2020 May 27;11(1):207</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32460839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2013 Nov;100(2):407-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23994190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2020 Feb 19;24(1):56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32070391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2020 Aug 20;64(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32661006</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000089 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000089 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33889318
   |texte=   Experimental therapies under investigation for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33889318" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Experimental therapies under investigation for COVID-19.

Experimental therapies under investigation for COVID-19.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki